Finance

Lists
Q1 2027 earnings
See results
4521:TYO
Kaken Pharmaceutical Co Ltd
Â¥4,000.00
+2.56%
(+100.00) 1D
Aug 10, 3:30:00 PM GMT+9  ·   JPY
All symbols
SymbolPriceChange% Change
Generating top insights for 4521...
Open
Â¥3,970
High
Â¥4,050
Low
Â¥3,915
Mkt. cap
176.56B
Avg. vol.
129.97K
Volume
284.10K
Dividend
4.75%
Quarterly dividend
Â¥48
Ex-dividend date
Sep 29, 2026
P/E ratio
14.69
52-wk high
Â¥4,445
52-wk low
Â¥3,540
EPS
Â¥272
Shares outstanding
39.72M
No. of employees
1K
Open
Â¥3,970
High
Â¥4,050
Low
Â¥3,915
Mkt. cap
176.56B
Avg. vol.
129.97K
Volume
284.10K
Dividend
4.75%
Quarterly dividend
Â¥48
Ex-dividend date
Sep 29, 2026
P/E ratio
14.69
52-wk high
Â¥4,445
52-wk low
Â¥3,540
EPS
Â¥272
Shares outstanding
39.72M
No. of employees
1K
About Kaken Pharmaceutical Co Ltd
CEO-
Employees1.11K
Founded1917
Headquarters-
SectorPharmaceutical industry
Websitekaken.co.jp
Last report
Aug 7, 2026
Fiscal period
Q1 2027
EPS / Est. (JPY)
- / -
Revenue / Est. (JPY)
30.16B / -
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
20.49B
18.26B
19.25B
30.16B
Cost of goods sold
8.78B
9.01B
10.09B
9.18B
Cost of revenue
8.78B
9.01B
10.09B
9.18B
Research and development expenses
6.29B
3.97B
4.94B
4.60B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.23B
4.92B
4.92B
5.47B
Operating expense
11.52B
8.90B
10.62B
10.07B
Total operating expenses
20.30B
17.91B
20.71B
19.25B
Operating income
187.00M
354.00M
-1.46B
10.90B
Other non operating income
-27.00M
34.00M
43.00M
8.00M
EBT including unusual items
988.00M
588.00M
328.00M
11.24B
EBT excluding unusual items
184.00M
598.00M
-1.41B
11.26B
Income tax expense
267.00M
182.00M
-418.00M
2.80B
Effective tax rate
27.02%
-
-127.44%
24.93%
Other operating expenses
-
-
-
-
Net income
721.00M
406.00M
746.00M
8.44B
Net profit margin
3.52%
-
3.87%
27.99%
Earnings per share
-
-
-
-
Interest and investment income
78.00M
324.00M
91.00M
393.00M
Interest expense
-11.00M
-11.00M
-13.00M
-14.00M
Net interest expenses
67.00M
313.00M
78.00M
379.00M
Depreciation and amortization charges
-
-
752.00M
-
EBITDA
922.00M
992.50M
-624.75M
-
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps